Ontruzant Trastuzumab-Dttb Injection 420 mg **Refrigeration Required** (RX)

Ontruzant Trastuzumab-Dttb Injection 420 mg is a cancer medicine used to treat breast cancer, stomach cancer, and other types of cancer that overexpress the HER2 protein. It belongs to a class of drugs called monoclonal antibodies, which work by targeting and inhibiting the activity of HER2 receptors on cancer cells. By blocking these receptors, Ontruzant helps to slow or stop the growth and spread of cancer cells in the body. This medication is administered through injection by a healthcare professional.

Ontruzant Trastuzumab-Dttb is a monoclonal antibody that works by binding to a protein called HER2, which is found on the surface of some cancer cells. When this antibody binds to HER2, it blocks the growth and spread of cancer cells. This helps to slow down or stop the growth of cancer and can also help the body’s immune system to recognize and attack cancer cells. It is commonly used to treat breast cancer that overexpresses the HER2 protein.

Brand: Organon Biosimilar
Strength: 420 mg
NDC: 78206-0148-01
Type: Powder Vial